Lipase supplementation therapy: Standards, alternatives, and perspectives

Pancreas

Volumn 26, Issue 1, 2003, Pages 1-7

  Layer, Peter ^a   Keller, Jutta ^a  

^a ISRAELITISCHES KRANKENHAUS   (Germany)

Author keywords

Bacterial lipase; Bovine lipase; Fungal lipase; Gastric lipase; Human lipase; Porcine lipase

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL ENZYME; CREON 10,000; CREON 5; ENZYM LEFAX; FUNGAL ENZYME; HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PANCREAS ENZYME; PANCREASE MT 4; PANCREATIN; PANCRELIPASE; PANKREON 10,000; PANKREON 28,000; PANZYTRAT 10,000; PROKINETIC AGENT; PROTON PUMP INHIBITOR; SIMETHICONE; TRIACYLGLYCEROL LIPASE; ULTRASE MT 12;

CELIAC DISEASE; CHRONIC PANCREATITIS; CROHN DISEASE; DIET SUPPLEMENTATION; DRUG FORMULATION; ENZYME DEFICIENCY; ENZYME THERAPY; FAT INTAKE; GASTRECTOMY; GASTROINTESTINAL DISEASE; HUMAN; MALABSORPTION; NONHUMAN; PANCREAS DUCT STENOSIS; PANCREAS INSUFFICIENCY; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SMALL INTESTINE RESECTION; STEATORRHEA; STOMACH EMPTYING; TABLET FORMULATION; TREATMENT INDICATION; TROPICAL SPRUE; ZOLLINGER ELLISON SYNDROME;

ANIMALS; BACTERIA; CATTLE; CELIAC DISEASE; CHRONIC DISEASE; EXOCRINE PANCREATIC INSUFFICIENCY; FATS; FUNGI; GASTROINTESTINAL AGENTS; HUMANS; LIPASE; PANCREAS; PANCREATIN; PANCREATITIS; SWINE;

EID: 0037216282     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200301000-00001     Document Type: Review

References (67)

1. Carriere F, Barrowman JA, Verger R, et al. Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans. Gastroenterology 1993;105:876-88.
2. Sternby B, Holtmann G, Kelly DG, et al. Effect of gastric or duodenal nutrient infusion on gastric and pancreatic lipase secretion. Gastroenterology 1992;102:292.
3. Moreau H, Laugier R, Gargouri Y, et al. Human preduodenal lipase is entirely of gastric fundic origin. Gastroenterology 1988;95:1221-6.
4. Keller J, Runzi M, Goebell H, et al. Duodenal and ileal nutrient deliveries regulate human intestinal motor and pancreatic responses to a meal. Am J Physiol 1997;272:G632-7.
5. Holtmann G, Kelly DG, Sternby B, et al. Survival of human pancreatic enzymes during small bowel transit: Effect of nutrients, bile acids, and enzymes. Am J Physiol 1997:273:G553-8.
6. Layer P, von der O, Hoist JJ, et al. Altered postprandial motility in chronic pancreatitis: Role of malabsorption. Gastroenterology 1997;112:1624-34.
7. Groger G, Cherian L, Goebell H, et al. Ileal inhibition and modulation of carbachol-stimulated proximal small intestinal motor functions in humans. Z Gastroenterol 1996;34:791-4.
8. Layer P, Holst JJ, Grandt D, et al. Ileal release of glucagon-like peptide-1 (GLP-1). Association with inhibition of gastric acid secretion in humans. Dig Dis Sci 1995;40:1074-82.
9. Layer P, Peschel S, Schlesinger T, et al. Human pancreatic secretion and intestinal motility: Effects of ileal nutrient perfusion. Am J Physiol 1990;258:G196-201.
10. Keller J, Conrads H, Hoist JJ, et al. The ratios between pancreatic secretory enzymes are modulated by physiologic ileal lipid concentrations. Pancreas 1998;17:442.
11. Keller J, VanKrieken A, Goebell H, et al. Differential responses of pancreatic secretion and intestinal motility to graded ileal nutrient perfusion. Gaatroenterology 1997;112:452.
12. Layer P, Yamamoto H, Kalthoff L, et al. The different courses of early- and late-onset on.set idiopathic and alcoholic chronic pancreatitis. Gastroenterology 1994;107:1481-7.
13. DiMagno EP, Go WL, Summerskill WH. Impaired cholecystokinin-pancreozymin secretion, intraluminal dilution, and maldigestion of fat in sprue. Gastroenterology 1972;63:25-32.
14. Maton PN, Selden AC, Fitzpatrick ML, et al. Defective gallbladder emptying and cholecystokinin release in celiac disease. Reversal by gluten-free diet. Gastroenterology 1985;88:391-6.
15. Keller J, Melle U, Hoene K, et al. Decreased digestive stimulation of pancreatic enzyme secretion in Crohn's disease. Pancreas 2000;21:453.
16. DiMagno EP, Malagelada JR, Go VL, et al. Fate of orally ingested enzymes in pancreatic insufficiency: Comparison of two dosage schedules. N Engl J Med 1977;296:1318-22.
17. Degen LP, Beglinger C. Postoperative gastrointestinal physiology following operations on the stomach. Pancreatology 2001;1:9-13.
18. Friess H, Tempia-Caliera AA, Büchler MW. Indication for pancreatic enzyme substitution following gastric resection. Pancreatology 2001;1:41-8.
19. Layer P, Melle U. Indication for pancreatic enzyme substitution following small intestinal resection (short bowel syndrome). Pancreatology 2001;1(suppl 1):49-54.
20. DiMagno EP, Clain JE, Layer P. Chronic pancreatitis. In: Go VL, ed. The Pancreas: Biology, Pathobiology and Disease. 2nd Ed. New York: Raven Press, 1993:665-706.
21. Layer PH, DiMagno EP. Natural histories of alcoholic and idiopathic chronic pancreatitis, Pancreas 1996;12:318-20.
22. Layer P, Holtmann G. Pancreatic enzymes in chronic pancreatitis. Int J Pancreatol 1994;15:1-11.
23. DiMagno EP, Layer P. Human exocrine pancreatic enzyme secretion. In: Go VL, ed. The Pancreas: Biology, Pathobiology and Diseases. 2nd Ed. New York: Raven Press, 1993:275-300.
24. Layer P, Go VL, DiMagno EP. Fate of pancreatic enzymes during small intestinal aboral transit in humans. Am J Physiol 1986;251:G475-80.
25. Layer P, Jansen JB, Cherian L, et al. Feedback regulation of human pancreatic secretion: Effects of protease inhibition on duodenal delivery and small intestinal transit of pancreatic enzymes. Gastroenterology 1990;98:1311-9.
26. Layer P, Ohe M, Groeger G, et al. Luminal availability and digestive efficacy of substituted enzymes in pancreatic insufficiency. Pancreas 1992;7:745.
27. Keller J, Conrads H, Goebell H, et al. Differential responses of human pancreatic and biliary secretion to graded ileal lipid perfusion. Digestion 1998;59:206.
28. DiMagno EP, Go VL, Summerskill WH. Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 1973;288:813-5.
29. Read NW, McFarlane A, Kinsman RI, et al. Effect of infusion of nutrient solutions into the ileum on gastrointestinal transit and plasma levels of neurotensin and enteroglucagon. Gastroenterology 1984;86:274-80.
30. Spiller RC, Trotman IF, Adrian TE, et al. Further characterisation of the "ileal brake" reflex in man - Effect of ileal infusion of partial digests of fat, protein, and starch on jejunal motility and release of neurotensin, enteroglucagon, and peptide YY. Gut 1988;29:1042-51.
31. Layer P, Schlesinger T, Groger G, et al. Modulation of human periodic interdigestive gastrointestinal motor and pancreatic function by the ileum. Pancreas 1993;8:426-32.
32. Klass HJ, Sandle GI, Kay PM, et al. Quantitation of tryptic responses to endogenous and exogenous stimulation in chronic pancreatitis. Digestion 1986;35:95-101.
33. Gregory PC. Gastrointestinal pH, motility/transit and permeability in cystic fibrosis. J Pediatr Gastroenterol Nutr 1996;23:513-23.
34. Nakamura T, Takebe K, Ishii M, et al. Study of gastric emptying in patients with pancreatic diabetes (chronic pancreatitis) using acetaminophen and isotope. Acta Gastroenterol Belg 1996;59:177.
35. Muller MW, Friess H, Beget H, et al. Gastric emptying following pyloruspreserving Whipple and duodenum-preserving pancreatic head resection in patients with chronic pancreatitis. Am J Surg 1997;173:257-63.
36. Slaff J, Jacobson D, Tillman CR, et al. Protease-specific suppression of pancreatic exocrine secretion. Gastroenterology 1984;87:44-52.
37. Layer P, Keller J, Lankisch A. Pancreatic enzyme replacement therapy. Curr Gastroenterol Rep 2001;3:101-8.
38. FitzSimmons SC, Burkhart GA, Borowitz D. et al. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med 1997;336:1283-9.
39. Mac Sweeney EJ, Oades PJ, Buchdahl R, et al. Relation of thickening of colon wall to pancreatic-enzyme treatment in cystic fibrosis. Lancet 1995;345:752-6.
40. Bansi DS, Price A, Russell C, et al. Fibrosing colonopathy in an adult owing to over use of pancreatic enzyme supplements. Gut 2000;46:283-5.
41. Lankisch PG, Layer P. Chronische Pankreatitis: Update - Diagnostik und Therapie 2000. Deutsches Ärzteblatt 2000;97:A2169-77.
42. Regan PT, Malagelada JR, DiMagno EP, et al. Rationale for the use of cimetidine in pancreatic insufficiency. Mayo Clin Proc 1978;53:79-83.
43. Carroccio A, Pardo F, Montalto G, et al. Use of famotidine in severe exocrine pancreatic insufficiency with persistent maldigestion on enzymatic replacement therapy: A long-term study in cystic fibrosis. Dig Dis Sci 1992;37:1441-6.
44. Heijerman HG, Lamers CB, Bakker W. Omeprazole enhances the efficacy of pancreatin (Pancrease) in cystic fibrosis. Ann Intern Med 1991;114:200-1.
45. DiMagno EP. Gastric acid suppression and treatment of severe exocrine pancreatic insufficiency. Baillieres Best Pract Res Clin Gastroenterol 2001;15:477-86.
46. Casellas F, Guarner L, Vaquero E, et al. Hydrogen breath test with glucose in exocrine pancreatic insufficiency. Pancreas 1998;16:481-6.
47. Caliari S, Benini L, Sembenini C, et al. Medium-chain triglyceride absorption in patients with pancreatic insufficiency. Scand J Gastroenterol 1996:31:90-4.
48. Kolbel C, Layer P, Hotz J, et al. Effect of an acid protected, micro-encapsulated pancreatin preparation on pancreatogenic steatorrhea. Med Klin (Barc) 1986;81:85-6.
49. Lankisch PG, Lembcke B, Goke B, et al. Therapy of pancreatogenic steatorrhoea: Does acid protection of pancreatic enzymes offer any advantage? Z Gastroenterol 1986;24:753-7.
50. Meyer JH, Lake R. Mismatch of duodenal deliveries of dietary fat and pancreatin from enterically coated microspheres. Pancreas 1997;15:226-35.
51. Hendeles L, Dorf A, Stecenko A, et al. Treatment failure after substitution of generic pancrelipase capsules. Correlation with in vitro lipase activity. JAMA 1990;263:2459-61.
52. DiMagno EP, Malagelada JR, Go VL. Relationship between alcoholism and pancreatic insufficiency. Ann N Y Acad Sci 1975;252:200-7.
53. Dutta SK, Rubin J, Harvey J. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency. Gastroenterology 1983;84:476-82.
54. Smyth RL, Ashby D, O'Hea U, et al. Fibrosing colonopathy in cystic fibrosis: Results of a case-control study. Lancet 1995;346:1247-51.
55. van Velzen D, Ball LM, Dezfulian AR, et al. Comparative and experimental pathology of fibrosing colonopathy. Postgrad Med J 1996;72(suppl 2):S39-48.
56. Prescott P, Bakowski MT. Pathogenesis of fibrosing colonopathy: The role of methacrylic acid copolymer. Pharmacoepidemiology and Drug Safety 1999;8: 377-84.
57. Thiruvengadam R, DiMagno EP. Inactivation of human lipase by proteases. Am J Physiol 1988;255:G476-81.
58. Schneider MU, Knoll-Ruzicka ML, Domschke S, et al. Pancreatic enzyme replacement therapy: Comparative effects of conventional and enteric-coated microspheric pancreatin and acid-stable fungal enzyme preparations on steatorrhea in chronic pancreatitis. Hepatogastroenterology 1985;32:97-102.
59. Moreau J, Bouisson M, Saint MGM, et al. Comparison of fungal lipase and pancreatic lipase in exocrine pancreatic insufficiency in man: Study of their in vitro properties and intraduodenal bioavailability. Gastroenterol Clin Biol 1988;12:787-92.
60. Zentler-Munro PL. Assoufi BA, Balasubramanian K, et al. Therapeutic potential and clinical efficacy of acid-resistant fungal lipase in the treatment of pancreatic steatorrhoea due to cystic fibrosis. Pancreas 1992;7:311-9.
61. Raimondo M, DiMagno EP. Lipolytic activity of bacterial lipase survives better than that of porcine lipase in human gastric and duodenal content. Gastroenterology 1994:107:231-5.
62. Suzuki A, Mizumoto A, Sarr MG, et al. Bacterial lipase and high-fat diets in canine exocrine pancreatic insufficiency: A new therapy of steatorrhea? Gastroenterology 1997;112:2048-55.
63. Suzuki A, Mizumoto A, Rerknimitr R, et al. Effect of bacterial or porcine lipase with low- or high-fat diets on nutrient absorption in pancreatic-insufficient dogs. Gastroenterology 1999;116:431-7.
64. Kuhel DG, Zheng S, Tso P, et al. Adenovirus-mediated human pancreatic lipase gene transfer to rat bile: Gene therapy of fat malabsorption. Am J Physiol Gastrointest Liver Physiol 2000;279:G1031-6.
65. Maeda H, Danel C, Crystal RG. Adenovirus-mediated transfer of human lipase complementary DNA to the gallbladder. Gastroenterology 1994; 106:1638-44.
66. Layer P, Keller J. Pancreatic enzymes: Secretion and luminal nutrient digestion in health and disease. J Clin Gastroenterol 1999;28:3-10.
67. Lankisch PG. Appropriate pancreatic function tests and indications for pancreatic enzyme therapy following surgical procedures on the pancreas. Pancreatology 2001;1:14-26.